Get my own profile
Public access
View all72 articles
9 articles
available
not available
Based on funding mandates
Co-authors
Sabine LinnProfessor of Translational Oncology - Utrecht University; Group leader NKI AmsterdamVerified email at nki.nl
Rene BernardsNetherlands Cancer InstituteVerified email at nki.nl
fabien reyalInstitut Curie. Department of SurgeryVerified email at curie.fr
Jelle WesselingGroup Leader, Netherlands Cancer InstituteVerified email at nki.nl
Howard Y. ChangStanford UniversityVerified email at stanford.edu
David HuntsmanBC Cancer AgencyVerified email at bccancer.bc.ca
Saraswati SukumarProfessor of OncologyVerified email at jhmi.edu
Anita LangerødResearcher, Oslo University HospitalVerified email at rr-research.no
Ali BashashatiUniversity of British Columbia/Vancouver Coastal Health Research InstituteVerified email at bccrc.ca
Sohrab ShahMemorial Sloan Kettering Cancer CenterVerified email at mskcc.org
Gordon MillsOregon Health & Science UniversityVerified email at ohsu.edu
Pedram ArganiProfessor of Pathology and Oncology, Johns Hopkins UniversityVerified email at jhmi.edu
Rachael NatrajanThe Institute of Cancer ResearchVerified email at icr.ac.uk
Petra M NederlofNetherlands Cancer Institute NKIVerified email at nki.nl
Michael AnglesioAssistant Professor, Department of Obstetrics & Gynaecology, University of British ColumbiaVerified email at ubc.ca
Manolis KellisProfessor of Computer Science, MIT and Broad InstituteVerified email at mit.edu
Michael F. Linindependent (mlin.net LLC)Verified email at mlin.net
Jos JonkersSenior Group Leader, Division of Molecular Pathology, Netherlands Cancer Institute, Oncode InstituteVerified email at nki.nl
Joe GrayBiomedical Engineering, Oregon Health and Science UniversityVerified email at ohsu.edu
Zhi HuReasech Assistant Professor, Department of Biomedical Engineering, OHSUVerified email at ohsu.edu
Follow
Hugo M. Horlings
MD PhD, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Verified email at nki.nl - Homepage